ArticleCurrent cancer drug targets2025

Anti-Resistant Strategies: Icotinib Derivatives as Promising Non-Small Cell Lung Cancer Therapeutics.

Zhiwei Zhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.